Ibrance 125 MG Oral Tablet

RxCUI: 2284106
RxNorm name: Ibrance 125 MG Oral Tablet
Display name: Ibrance 125 MG Oral Tablet
Full name: Ibrance 125 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ibrance	PALBOCICLIB	U.S. Pharmaceuticals	89a142d5-7e61-48bf-9e77-e2cd124c4792	2026-07-06	Warnings, Adverse reactions	Exact identifier rxcui: 2284106
Ibrance	PALBOCICLIB	Pfizer Laboratories Div Pfizer Inc	fecbdd7d-b729-41b5-9872-231b8fe104ce	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 2284106

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
fecbdd7d-b729-41b5-9872-231b8fe104ce	Ibrance 125 MG Oral Tablet	PSN	12	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260225
fecbdd7d-b729-41b5-9872-231b8fe104ce	Ibrance 125 MG Oral Tablet	SY	12	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260225
fecbdd7d-b729-41b5-9872-231b8fe104ce	palbociclib 125 MG Oral Tablet [Ibrance]	SBD	12	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260225
89a142d5-7e61-48bf-9e77-e2cd124c4792	Ibrance 125 MG Oral Tablet	SY	10	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260530
89a142d5-7e61-48bf-9e77-e2cd124c4792	Ibrance 125 MG Oral Tablet	PSN	10	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260530
89a142d5-7e61-48bf-9e77-e2cd124c4792	palbociclib 125 MG Oral Tablet [Ibrance]	SBD	10	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 2015	20260530